Renaissance Technologies’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-13,921
Closed -$16K 4307
2023
Q3
$16K Sell
13,921
-3,345
-19% -$3.85K ﹤0.01% 3551
2023
Q2
$23K Buy
17,266
+6,241
+57% +$8.31K ﹤0.01% 3753
2023
Q1
$12K Buy
11,025
+900
+9% +$980 ﹤0.01% 3878
2022
Q4
$24K Sell
10,125
-17,600
-63% -$41.7K ﹤0.01% 3940
2022
Q3
$119K Buy
+27,725
New +$119K ﹤0.01% 3537
2022
Q2
Sell
-3,172
Closed -$27K 4726
2022
Q1
$27K Buy
3,172
+1,916
+153% +$16.3K ﹤0.01% 3985
2021
Q4
$14K Buy
+1,256
New +$14K ﹤0.01% 3853
2021
Q3
Sell
-21,207
Closed -$394K 4054
2021
Q2
$394K Buy
21,207
+4,600
+28% +$85.5K ﹤0.01% 3060
2021
Q1
$413K Buy
16,607
+12,148
+272% +$302K ﹤0.01% 2981
2020
Q4
$90K Buy
+4,459
New +$90K ﹤0.01% 3264
2020
Q3
Sell
-3,729
Closed -$147K 3865
2020
Q2
$147K Buy
3,729
+1,874
+101% +$73.9K ﹤0.01% 3216
2020
Q1
$78K Buy
1,855
+873
+89% +$36.7K ﹤0.01% 3269
2019
Q4
$166K Buy
982
+340
+53% +$57.5K ﹤0.01% 3229
2019
Q3
$241K Buy
642
+59
+10% +$22.1K ﹤0.01% 3093
2019
Q2
$324K Buy
583
+75
+15% +$41.7K ﹤0.01% 3150
2019
Q1
$591K Buy
508
+25
+5% +$29.1K ﹤0.01% 2873
2018
Q4
$547K Buy
483
+167
+53% +$189K ﹤0.01% 2830
2018
Q3
$478K Buy
316
+150
+90% +$227K ﹤0.01% 2860
2018
Q2
$211K Buy
166
+157
+1,744% +$200K ﹤0.01% 3063
2018
Q1
$86K Buy
+9
New +$86K ﹤0.01% 3273
2016
Q2
Sell
-2
Closed -$221K 3641
2016
Q1
$221K Buy
+2
New +$221K ﹤0.01% 3053